Canada · Health Canada Drug Product Database
LENVIMA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 93643
- DIN
- 02450291
- Form
- Capsule
- Company as listed by source
- EISAI LIMITED
- Source status
- Marketed (2016-03-31)
- Source last updated
- 2026-08-25
Source-listed ingredients
- LENVATINIB (LENVATINIB MESYLATE) — 24 MG — per 1 DOSE
These values do not establish equivalence or a dose recommendation.
Packages
- 90 (60 X 10mg, 30 X 4mg)
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →